Defining Neurobiological Links Between Substance Use and Mental Illness

Abroad (travel likely)Recruiting

Conditions

Major Depressive Disorder · Substance Use Disorder · Normal Physiology

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Institute on Drug Abuse, Baltimore, Maryland, United States
Contact: Study coordinator (Kevin Noemer, M.A.) · kevin.noemer@nih.gov · 667-312-5225

Study leads

Amy C Janes, Ph.D.
Principal Investigator
National Institute on Drug Abuse (NIDA)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Major Depressive Disorder (MDD)

Abroad (travel likely)RecruitingPHASE2

Bentonville, United States · Little Rock, United States

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Major Depressive Disorder

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · Little Rock, United States

Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV

Major Depressive Disorder · Anxiety Depression · HIV

Abroad (travel likely)RecruitingPHASE2

Boston, United States

Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy

Electroconvulsive Therapy · Major Depressive Disorder · Magnetic Seizure Therapy

Abroad (travel likely)Recruiting

Hefei, China